July 26, 2018

[PET scans confirm] Trial of new Alzheimer’s drug shows promising results

The treatment was administered at different dosing levels. After 18 months, those receiving the highest dose had an 81 percent reduction in amyloid buildup as measured in PET scans and a 30 percent reduction in clinical indicators of early Alzheimer’s. {read more here}